In a research note issued to investors, Ching-Yi Lin at H.C. Wainwright Reiterated their Hold rating on Celladon Corp (NASDAQ:CLDN). In the year following Ching’s ratings, the stocks covered yield an average return of -34.5% according to TipRanks.com.
Wall Street sell-side analysts have placed a $2.5 one year price target on Celladon Corporation (NASDAQ:CLDN). This is the consensus average based on 2 firms who have recently issued reports on the equity.
The average recommendation is the arithmetical average of the individual analyst ratings contributed by sell-side research to produce a Consensus Analyst Rating for each stock. On a scale of 1 to 5 where 1 represents a Strong Buy and 5 represents a Strong Sell,Celladon Corporation (NASDAQ:CLDN) is ranked 3 based on 2 broker recommendations. Of the 2 analyst estimates, the most bullish sees the stock reaching $3 within the next 12 months while the most bearish analyst sees the stock at $2 within the year.
Taking a look at the long term growth prospects of the stock, sell-side analysts have a consensus mean earnings per share estimate for the current year of $N/A. The high end estimate for this time frame is $N/A with the low being $N/A.
According to analysts, Celladon Corporation (NASDAQ:CLDN) is expected to report earnings per share for the current fiscal quarter of $-0.38. This is the consensus mean estimate based on the individual covering sell-side firm’s reported numbers. The company last reported earnings for the period ending on 2015-03-31 of $-0.71.